- NOK5.14bn
- NOK5.07bn
- NOK699.77m
Brief: Medistim's MiraQTM Approved For Sale In Canada
Brief: Medistim Q3 EBIT Up At NOK 19.1 Mln
Brief: Medistims Newest Generation Miraqtm Is Approved For Sale In Japan
Brief: Medistim Q2 EBIT Rises To NOK 30.9 Mln
Brief: Medistim ASA Q1 EBIT NOK 19.9 Million
Brief: Medistim Q4 EBIT Up At NOK 27.8 Million
Brief: Medistim Q3 Operating Profit Falls To NOK 14.5 Mln
Brief: Medistim: Final Results From REQUEST Study Presented At EACTS
Brief: Medistim Q2 Operating Profit Rises To NOK 18.1 Million
Brief: Medistim Q1 EBIT Falls To NOK 13.6 Million
Brief: Medistim Q4 Sales Up At Nok 82.2 Million
Brief: Medistim joins GE Vingmed Ultrasound and Sensocure in joint project
Brief: Medistim Q3 EBIT up at NOK 19.4 mln
Brief: Medistim Q2 EBIT falls to NOK 13.6 million
Brief: Medistim receives clearance in China for sale of MiraQ
Brief: Medistim Q1 EBIT up at NOK 16.0 million
Brief: Medistim Q4 EBIT decreases to NOK 9.7 mln
Brief: Medistim establishes own subsidiary in Spain
Brief: Medistim establishes direct sales operations in Spain